KRAS and YAP1 converge to regulate EMT and tumor survival

Cell

Volumn 158, Issue 1, 2014, Pages 171-184

  Shao, Diane D ^a,b   Xue, Wen ^c   Krall, Elsa B ^a,b   Bhutkar, Arjun ^c   Piccioni, Federica ^b   Wang, Xiaoxing ^a,b   Schinzel, Anna C ^a,b   Sood, Sabina ^c   Rosenbluh, Joseph ^a,b   Kim, Jong W ^a,b   Zwang, Yaara ^a,b   Roberts, Thomas M ^a   Root, David E ^b   Jacks, Tyler ^b,c,d,e   Hahn, William C ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c KOCH INSTITUTE FOR INTEGRATIVE CANCER RESEARCH   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; PROTEIN FOS; RAS PROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR YAP1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL LINE; CANCER RESISTANCE; CANCER SURVIVAL; CELL TRANSFORMATION; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE REPRESSION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG CANCER; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

MURINAE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL SURVIVAL; COLONIC NEOPLASMS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; HCT116 CELLS; HUMANS; LUNG NEOPLASMS; MICE; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); RAS PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84904024982     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2014.06.004     Document Type: Article

References (68)

1. M.V. Baez, and G.L. Boccaccio Mammalian Smaug is a translational repressor that forms cytoplasmic foci similar to stress granules J. Biol. Chem. 280 2005 43131 43140
2. B.E. Bernstein, E. Birney, I. Dunham, E.D. Green, C. Gunter, M. Snyder ENCODE Project Consortium An integrated encyclopedia of DNA elements in the human genome Nature 489 2012 57 74
3. C. Brideau, B. Gunter, B. Pikounis, and A. Liaw Improved statistical methods for hit selection in high-throughput screening J. Biomol. Screen. 8 2003 634 647
4. F.D. Camargo, S. Gokhale, J.B. Johnnidis, D. Fu, G.W. Bell, R. Jaenisch, and T.R. Brummelkamp YAP1 increases organ size and expands undifferentiated progenitor cells Curr. Biol. 17 2007 2054 2060
5. X. Cao, S.L. Pfaff, and F.H. Gage YAP regulates neural progenitor cell number via the TEA domain transcription factor Genes Dev. 22 2008 3320 3334
6. G.Z. Cheng, J. Chan, Q. Wang, W. Zhang, C.D. Sun, and L.-H. Wang Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel Cancer Res. 67 2007 1979 1987
7. L. Chin, A. Tam, J. Pomerantz, M. Wong, J. Holash, N. Bardeesy, Q. Shen, R. O'Hagan, J. Pantginis, and H. Zhou et al. Essential role for oncogenic Ras in tumour maintenance Nature 400 1999 468 472
8. T. Deng, and M. Karin c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK Nature 371 1994 171 175
9. M. DuPage, A.L. Dooley, and T. Jacks Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase Nat. Protoc. 4 2009 1064 1072
10. S. Dupont, L. Morsut, M. Aragona, E. Enzo, S. Giulitti, M. Cordenonsi, F. Zanconato, J. Le Digabel, M. Forcato, and S. Bicciato et al. Role of YAP/TAZ in mechanotransduction Nature 474 2011 179 183
11. A. Eger, A. Stockinger, B. Schaffhauser, H. Beug, and R. Foisner Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity J. Cell Biol. 148 2000 173 188
12. K. Ehrenreiter, F. Kern, V. Velamoor, K. Meissl, G. Galabova-Kovacs, M. Sibilia, and M. Baccarini Raf-1 addiction in Ras-induced skin carcinogenesis Cancer Cell 16 2009 149 160
13. G.H. Fisher, S.L. Wellen, D. Klimstra, J.M. Lenczowski, J.W. Tichelaar, M.J. Lizak, J.A. Whitsett, A. Koretsky, and H.E. Varmus Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes Genes Dev. 15 2001 3249 3262
14. I.B. Fuchs, W. Lichtenegger, H. Buehler, W. Henrich, H. Stein, A. Kleine-Tebbe, and G. Schaller The prognostic significance of epithelial-mesenchymal transition in breast cancer Anticancer Res. 22 6A 2002 3415 3419
15. A. González-García, C.A. Pritchard, H.F. Paterson, G. Mavria, G. Stamp, and C.J. Marshall RalGDS is required for tumor formation in a model of skin carcinogenesis Cancer Cell 7 2005 219 226
16. S. Gupta, A.R. Ramjaun, P. Haiko, Y. Wang, P.H. Warne, B. Nicke, E. Nye, G. Stamp, K. Alitalo, and J. Downward Binding of ras to phosphoinositide 3-kinase p110α is required for ras-driven tumorigenesis in mice Cell 129 2007 957 968
17. W.C. Hahn, C.M. Counter, A.S. Lundberg, R.L. Beijersbergen, M.W. Brooks, and R.A. Weinberg Creation of human tumour cells with defined genetic elements Nature 400 1999 464 468
18. P.A. Jänne, N. Gray, and J. Settleman Factors underlying sensitivity of cancers to small-molecule kinase inhibitors Nat. Rev. Drug Discov. 8 2009 709 723
19. M. Jechlinger, K. Podsypanina, and H. Varmus Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction Genes Dev. 23 2009 1677 1688
20. H. Kajiyama, K. Shibata, M. Terauchi, M. Yamashita, K. Ino, A. Nawa, and F. Kikkawa Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells Int. J. Oncol. 31 2007 277 283
21. M. Karin The regulation of AP-1 activity by mitogen-activated protein kinases J. Biol. Chem. 270 1995 16483 16486
22. A. Kapoor, W. Yao, H. Ying, S. Hua, A. Liewen, Q. Wang, Y. Zhong, C.-J. Wu, A. Sadanandam, and B. Hu et al. Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer Cell 157 2014 185 197 this issue
23. S.M. Kiełbasa, H. Klein, H.G. Roider, M. Vingron, and N. Blüthgen TransFind - predicting transcriptional regulators for gene sets Nucleic Acids Res. 38 Web Server issue 2010 W275 W280
24. J.M. Lamar, P. Stern, H. Liu, J.W. Schindler, Z.-G. Jiang, and R.O. Hynes The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain Proc. Natl. Acad. Sci. USA 109 2012 E2441 E2450
25. K.S. Lau, and K.M. Haigis Non-redundancy within the RAS oncogene family: insights into mutational disparities in cancer Mol. Cells 28 2009 315 320
26. B.J. Ledwith, S. Manam, A.R. Kraynak, W.W. Nichols, and M.O. Bradley Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene Mol. Cell. Biol. 10 1990 1545 1555
27. K.-H. Lim, and C.M. Counter Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance Cancer Cell 8 2005 381 392
28. F. Mechta, D. Lallemand, C.M. Pfarr, and M. Yaniv Transformation by ras modifies AP1 composition and activity Oncogene 14 1997 837 847
29. T. Muramatsu, I. Imoto, T. Matsui, K.-I. Kozaki, S. Haruki, M. Sudol, Y. Shimada, H. Tsuda, T. Kawano, and J. Inazawa YAP is a candidate oncogene for esophageal squamous cell carcinoma Carcinogenesis 32 2011 389 398
30. A. O'Donnell, Z. Odrowaz, and A.D. Sharrocks Immediate-early gene activation by the MAPK pathways: what do and don't we know? Biochem. Soc. Trans. 40 2012 58 66
31. T. Oka, and M. Sudol Nuclear localization and pro-apoptotic signaling of YAP2 require intact PDZ-binding motif Genes Cells 14 2009 607 615
32. M. Ota, and H. Sasaki Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling Development 135 2008 4059 4069
33. M. Overholtzer, J. Zhang, G.A. Smolen, B. Muir, W. Li, D.C. Sgroi, C.-X. Deng, J.S. Brugge, and D.A. Haber Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon Proc. Natl. Acad. Sci. USA 103 2006 12405 12410
34. D. Pan The hippo signaling pathway in development and cancer Dev. Cell 19 2010 491 505
35. K. Podsypanina, K. Politi, L.J. Beverly, and H.E. Varmus Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras Proc. Natl. Acad. Sci. USA 105 2008 5242 5247
36. Y. Pylayeva-Gupta, E. Grabocka, and D. Bar-Sagi RAS oncogenes: weaving a tumorigenic web Nat. Rev. Cancer 11 2011 761 774
37. B.V.V.G. Reddy, and K.D. Irvine Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins Dev. Cell 24 2013 459 471
38. E. Reichmann, H. Schwarz, E.M. Deiner, I. Leitner, M. Eilers, J. Berger, M. Busslinger, and H. Beug Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion Cell 71 1992 1103 1116
39. J. Rosenbluh, D. Nijhawan, A.G. Cox, X. Li, J.T. Neal, E.J. Schafer, T.I. Zack, X. Wang, A. Tsherniak, and A.C. Schinzel et al. β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis Cell 151 2012 1457 1473
40. E. Saez, S.E. Rutberg, E. Mueller, H. Oppenheim, J. Smoluk, S.H. Yuspa, and B.M. Spiegelman c-fos is required for malignant progression of skin tumors Cell 82 1995 721 732
41. S.V. Sharma, and J. Settleman Oncogene addiction: setting the stage for molecularly targeted cancer therapy Genes Dev. 21 2007 3214 3231
42. A. Singh, P. Greninger, D. Rhodes, L. Koopman, S. Violette, N. Bardeesy, and J. Settleman A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival Cancer Cell 15 2009 489 500
43. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. USA 102 2005 15545 15550
44. M. Sudol Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product Oncogene 9 1994 2145 2152
45. M. Sudol YAP1 oncogene and its eight isoforms Oncogene 32 2012 3922
46. G. Suske The Sp-family of transcription factors Gene 238 1999 291 300
47. J.H. Taube, J.I. Herschkowitz, K. Komurov, A.Y. Zhou, S. Gupta, J. Yang, K. Hartwell, T.T. Onder, P.B. Gupta, and K.W. Evans et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes Proc. Natl. Acad. Sci. USA 107 2010 15449 15454
48. M.D. To, R.D. Rosario, P.M.K. Westcott, K.L. Banta, and A. Balmain Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis Oncogene 32 2013 4028 4033
49. D.A. Tuveson, A.T. Shaw, N.A. Willis, D.P. Silver, E.L. Jackson, S. Chang, K.L. Mercer, R. Grochow, H. Hock, and D. Crowley et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects Cancer Cell 5 2004 375 387
50. A. Vassilev, K.J. Kaneko, H. Shu, Y. Zhao, and M.L. DePamphilis TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm Genes Dev. 15 2001 1229 1241
51. K. Wang, C. Degerny, M. Xu, and X.-J. Yang YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease Biochem. Cell Biol. 87 2009 77 91
52. Y. Wang, V.N. Ngo, M. Marani, Y. Yang, G. Wright, L.M. Staudt, and J. Downward Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells Oncogene 29 2010 4658 4670
53. S.E. Witta, R.M. Gemmill, F.R. Hirsch, C.D. Coldren, K. Hedman, L. Ravdel, B. Helfrich, R. Dziadziuszko, D.C. Chan, and M. Sugita et al. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines Cancer Res. 66 2006 944 950
54. C.E. Wong, J.S. Yu, D.A. Quigley, M.D. To, K.Y. Jen, P.Y. Huang, R. Del Rosario, and A. Balmain Inflammation and Hras signaling control epithelial-mesenchymal transition during skin tumor progression Genes Dev. 27 2013 670 682
55. W. Xue, E. Meylan, T.G. Oliver, D.M. Feldser, M.M. Winslow, R. Bronson, and T. Jacks Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma Cancer Discov. 1 2011 236 247
56. X. Yang, J.S. Boehm, X. Yang, K. Salehi-Ashtiani, T. Hao, Y. Shen, R. Lubonja, S.R. Thomas, O. Alkan, and T. Bhimdi et al. A public genome-scale lentiviral expression library of human ORFs Nat. Methods 8 2011 659 661
57. L. Zender, M.S. Spector, W. Xue, P. Flemming, C. Cordon-Cardo, J. Silke, S.-T. Fan, J.M. Luk, M. Wigler, and G.J. Hannon et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach Cell 125 2006 1253 1267
58. J. Zhang, J.-Y. Ji, M. Yu, M. Overholtzer, G.A. Smolen, R. Wang, J.S. Brugge, N.J. Dyson, and D.A. Haber YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway Nat. Cell Biol. 11 2009 1444 1450
59. X. Zhang, F.A. Grusche, and K.F. Harvey Control of tissue growth and cell transformation by the Salvador/Warts/Hippo pathway PLoS ONE 7 2012 e31994
60. B. Zhao, X. Wei, W. Li, R.S. Udan, Q. Yang, J. Kim, J. Xie, T. Ikenoue, J. Yu, and L. Li et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control Genes Dev. 21 2007 2747 2761
61. B. Zhao, Q.-Y. Lei, and K.-L. Guan The Hippo-YAP pathway: new connections between regulation of organ size and cancer Curr. Opin. Cell Biol. 20 2008 638 646
62. B. Zhao, X. Ye, J. Yu, L. Li, W. Li, S. Li, J. Yu, J.D. Lin, C.-Y. Wang, and A.M. Chinnaiyan et al. TEAD mediates YAP-dependent gene induction and growth control Genes Dev. 22 2008 1962 1971
63. J. Zuber, K. McJunkin, C. Fellmann, L.E. Dow, M.J. Taylor, G.J. Hannon, and S.W. Lowe Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi Nat. Biotechnol. 29 2011 79 83
64. W.J. Kent, C.W. Sugnet, T.S. Furey, K.M. Roskin, T.H. Pringle, A.M. Zahler, and D. Haussler The human genome browser at UCSC Genome Res. 12 2002 996 1006
65. J. Moffat, D.A. Grueneberg, X. Yang, S.Y. Kim, A.M. Kloepfer, G. Hinkle, B. Piqani, T.M. Eisenhaure, B. Luo, and J.K. Grenier et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen Cell 124 2006 1283 1298
66. D.E. Root, N. Hacohen, W.C. Hahn, E.S. Lander, and D.M. Sabatini Genome-scale loss-of-function screening with a lentiviral RNAi library Nat. Methods 3 2006 715 719
67. C. Trapnell, L. Pachter, and S.L. Salzberg TopHat: discovering splice junctions with RNA-Seq Bioinformatics 25 2009 1105 1111
68. C. Trapnell, B.A. Williams, G. Pertea, A. Mortazavi, G. Kwan, M.J. van Baren, S.L. Salzberg, B.J. Wold, and L. Pachter Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation Nat. Biotechnol. 28 2010 511 515